The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network.
Animals
CD3 Complex
/ genetics
Cell Differentiation
/ immunology
Mice
Mice, Inbred C57BL
Mice, Transgenic
Pneumonia, Pneumocystis
/ immunology
Protein Interaction Maps
/ immunology
Proteomics
/ methods
Receptors, Antigen, T-Cell, alpha-beta
/ metabolism
Signal Transduction
/ immunology
Theilovirus
/ immunology
Thymocytes
/ immunology
Thymus Gland
/ metabolism
Journal
Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624
Informations de publication
Date de publication:
15 02 2019
15 02 2019
Historique:
received:
14
10
2016
accepted:
17
01
2019
entrez:
17
2
2019
pubmed:
17
2
2019
medline:
9
4
2020
Statut:
ppublish
Résumé
During αβ T cell development, T cell antigen receptor (TCR) engagement transduces biochemical signals through a protein-protein interaction (PPI) network that dictates dichotomous cell fate decisions. It remains unclear how signal specificity is communicated, instructing either positive selection to advance cell differentiation or death by negative selection. Early signal discrimination might occur by PPI signatures differing qualitatively (customized, unique PPI combinations for each signal), quantitatively (graded amounts of a single PPI series), or kinetically (speed of PPI pathway progression). Using a novel PPI network analysis, we found that early TCR-proximal signals distinguishing positive from negative selection appeared to be primarily quantitative in nature. Furthermore, the signal intensity of this PPI network was used to find an antigen dose that caused a classic negative selection ligand to induce positive selection of conventional αβ T cells, suggesting that the quantity of TCR triggering was sufficient to program selection outcome. Because previous work had suggested that positive selection might involve a qualitatively unique signal through CD3δ, we reexamined the block in positive selection observed in CD3δ
Identifiants
pubmed: 30770409
pii: 4/32/eaal2201
doi: 10.1126/sciimmunol.aal2201
pmc: PMC7252671
mid: NIHMS1026700
pii:
doi:
Substances chimiques
CD3 Complex
0
CD3delta antigen
0
Receptors, Antigen, T-Cell, alpha-beta
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NICHD NIH HHS
ID : U54 HD083091
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007386
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI097187
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM103841
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007425
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM065841
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS094765
Pays : United States
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Références
Int Immunol. 2007 Apr;19(4):523-34
pubmed: 17369191
Nat Rev Immunol. 2004 Apr;4(4):301-8
pubmed: 15057788
EMBO J. 1997 Mar 17;16(6):1360-70
pubmed: 9135151
Science. 1998 Aug 7;281(5378):835-8
pubmed: 9694657
Immunity. 2006 Oct;25(4):631-41
pubmed: 17045820
Immunity. 2009 Jun 19;30(6):777-88
pubmed: 19464197
Immunol Rev. 2007 Feb;215:178-88
pubmed: 17291288
Nat Rev Immunol. 2009 Mar;9(3):207-13
pubmed: 19151748
J Exp Med. 1998 Dec 21;188(12):2301-11
pubmed: 9858516
J Virol. 1999 May;73(5):3702-8
pubmed: 10196262
Sci Signal. 2013 Oct 15;6(297):ra92
pubmed: 24129702
Annu Rev Immunol. 2015;33:169-200
pubmed: 25493333
Immunity. 2009 Dec 18;31(6):897-908
pubmed: 20064448
Nature. 2006 Dec 7;444(7120):724-9
pubmed: 17086201
Int Immunol. 2000 Sep;12(9):1353-63
pubmed: 10967031
Nat Immunol. 2016 Sep;17(9):1093-101
pubmed: 27478940
Science. 1994 Mar 18;263(5153):1615-8
pubmed: 8128249
Nat Rev Immunol. 2005 Oct;5(10):772-82
pubmed: 16200080
Cell. 1994 Jan 14;76(1):17-27
pubmed: 8287475
Nucleic Acids Res. 2008 Dec;36(21):e140
pubmed: 18835849
Nature. 1993 May 13;363(6425):156-9
pubmed: 8483498
Science. 2009 Jan 23;323(5913):502-5
pubmed: 19164748
Nat Immunol. 2014 Apr;15(4):384-392
pubmed: 24584089
Nat Methods. 2006 Mar;3(3):191-7
pubmed: 16489336
Nat Immunol. 2004 Jun;5(6):597-605
pubmed: 15133507
Immunol Rev. 2009 Nov;232(1):7-21
pubmed: 19909352
Eur J Immunol. 1996 Oct;26(10):2350-5
pubmed: 8898944
J Immunol. 1997 Mar 1;158(5):2057-64
pubmed: 9036949
Lab Anim (NY). 2013 Feb;42(2):62-5
pubmed: 23340789
Immunity. 2004 Oct;21(4):515-26
pubmed: 15485629
Immunity. 2010 Mar 26;32(3):342-54
pubmed: 20346773
EMBO J. 1995 Jan 16;14(2):276-85
pubmed: 7835338
PLoS Biol. 2005 Nov;3(11):e356
pubmed: 16231973
Eur J Immunol. 1997 Aug;27(8):1831-7
pubmed: 9295014
Immunity. 1998 Dec;9(6):817-26
pubmed: 9881972
Mol Immunol. 1997 Oct;34(15):1067-82
pubmed: 9519765
Immunity. 1996 Aug;5(2):125-35
pubmed: 8769476
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2540-55
pubmed: 22889906
Nature. 2000 Jul 27;406(6794):426-30
pubmed: 10935641
J Immunol. 1997 Sep 15;159(6):2606-15
pubmed: 9300679
Clin Exp Pharmacol. 2012 Dec 21;2(3):S3.001
pubmed: 24535485
Proc Natl Acad Sci U S A. 1995 May 23;92(11):5042-6
pubmed: 7761445
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5454-63
pubmed: 27573839
Sci Signal. 2011 Sep 13;4(190):ra59
pubmed: 21917715
Nat Immunol. 2016 Jul;17(7):844-50
pubmed: 27213689
J Biol Chem. 2015 Oct 30;290(44):26422-9
pubmed: 26354432
Science. 1995 Jan 27;267(5197):515-8
pubmed: 7824949
Nat Rev Immunol. 2011 Jul 22;11(8):544-9
pubmed: 21779032
Nature. 2000 Jul 27;406(6794):422-6
pubmed: 10935640
Cell. 2014 Oct 9;159(2):333-45
pubmed: 25284152
Semin Immunol. 1999 Aug;11(4):263-72
pubmed: 10441212
J Biol Chem. 1994 Aug 12;269(32):20718-26
pubmed: 8051172
Immunity. 1997 Aug;7(2):221-31
pubmed: 9285407
J Immunol. 2011 Jul 15;187(2):870-8
pubmed: 21666056
Immunity. 2002 Mar;16(3):355-64
pubmed: 11911821
J Immunol. 2004 Jan 1;172(1):699-708
pubmed: 14688383
Science. 1998 Jul 24;281(5376):572-5
pubmed: 9677202
J Immunol. 2005 May 1;174(9):5593-601
pubmed: 15843558
Mol Syst Biol. 2005;1:2005.0023
pubmed: 16729058
Annu Rev Immunol. 2003;21:139-76
pubmed: 12414722
J Exp Med. 1996 Jul 1;184(1):9-18
pubmed: 8691153
J Immunol. 2001 Jun 1;166(11):6602-7
pubmed: 11359813
Immunol Today. 1994 Aug;15(8):362-6
pubmed: 7916949
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10338-43
pubmed: 10468609
Annu Rev Immunol. 1996;14:1-27
pubmed: 8717505
J Immunol. 2006 May 15;176(10):6147-54
pubmed: 16670323
Ther Adv Respir Dis. 2011 Feb;5(1):41-59
pubmed: 20736243
J Virol. 1998 Sep;72(9):7320-9
pubmed: 9696828
J Exp Med. 1984 Nov 1;160(5):1284-99
pubmed: 6208306
Curr Opin Immunol. 2002 Jun;14(3):299-305
pubmed: 11973126
Nat Immunol. 2012 Jan 19;13(2):121-8
pubmed: 22261968
Biores Open Access. 2013 Jun;2(3):222-6
pubmed: 23741635
Annu Rev Immunol. 1999;17:829-74
pubmed: 10358775
Sci Signal. 2016 Aug 02;9(439):rs7
pubmed: 27485017
Mol Ther. 2013 May;21(5):1087-95
pubmed: 23568262
Science. 2003 Mar 21;299(5614):1859-63
pubmed: 12649474
PLoS One. 2013 Aug 05;8(8):e70619
pubmed: 23940606
Immunol Lett. 2014 Sep;161(1):113-7
pubmed: 24877875
J Neuropathol Exp Neurol. 2009 Sep;68(9):1037-48
pubmed: 19680139
J Exp Med. 2002 Sep 16;196(6):793-803
pubmed: 12235212
Immunity. 2003 Jan;18(1):53-64
pubmed: 12530975
Immunity. 1995 Jul;3(1):79-86
pubmed: 7621079